Business · 25/03/1994Updated: 10/15/2026 · 1 min read
National Institute of Allergy and Infectious Diseases; Opportunity for a Cooperative Research and Development Agreement (CRADA) for the Clinical Development of a Live, Attenuated Cold-Adapted Influenza Virus Vaccine(s)
Summary
The National Institute of Allergy and Infectious Diseases (NIAID) is making available information related to the clinical development of a live, attenuated cold-adapted influenza virus vaccine(s) for confidential evaluation by interested and capable parties.
Original source language: Federal Register — Health and Human ServicesOpen original release →